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Abstract 
The study assessed the effect of selected antiretroviral drugs used in the management of 
HIV/AIDS on the oxidative stress marker malondialdehyde (as TBARs) and the antioxidant 
enzyme, Catalase, of the liver and kidney tissues of healthy albino rats. 0.43, 0.43, 0.27, and 
0.21mg/kg of Efavirenz, Abacavir, SNP 40 and Lamivudine respectively, were orally 
administered to four different groups of albino rats for seven days. The control group received 
normal saline. On the eighth day, the rats were sacrificed and the liver and kidney tissues were 
collected for Lipid peroxidation and Catalase activity analysis. Efavirenz and Lamivudine caused 
significant decrease (P<0.05) in lipid peroxidation in the liver while the reverse was obtained for 
Abacavir and SNP 40. SNP 40 caused a significant decrease (P<0.05) in lipid peroxidation in the 
kidney while the other drugs did not result in a significant change (p>0.05) compared to the 
191 
 
 SMU Medical Journal, Volume – 2, No. 1, January 2015 
control. All the drugs caused significant increase (P<0.05) in Catalase activity in the liver and a 
significant decrease (P<0.05) in Catalase activity in the kidney. Taken together, the present 
observation suggests that the effects of antiretroviral drugs on oxidative stress markers (such as 
MDA) and on antioxidant enzymes (such as catalase) in healthy as well as in HIV infected 
humans (by way of extrapolation) may vary from drug to drug and from organ to organ. We 
therefore advocate for extensive clinical research to investigate the influence of antiretroviral 
drugs on antioxidants enzymes in HIV and HIV/AIDS patients. 
Keywords: antiretroviral drugs, lipid peroxidation, liver, kidney, catalase. 
 
Introduction 
The acquired immunodeficiency syndrome (AIDS) is a fatal illness caused by a retrovirus known 
as the human immunodeficiency virus (HIV) that breaks down the body’s immune system that 
infects CD4+ cells initially and progressively leads to AIDS 1. The use of antiretroviral therapies 
(ART) is recommended worldwide for the management of HIV/AIDS. The World Health 
Organization (WHO) currently recommends first-line therapy with two nucleoside reverse 
transcriptase inhibitors (NRTIs) such as lamivudine and one non-nucleoside reverse transcriptase 
inhibitors (NNRTI) such as efavirenz 2.  
Oxidative stress (when free radical generation exceeds antioxidant defense) occurs in many 
human diseases and makes significant contributions to their pathogenesis 3. Free radicals are 
compounds possessing an unpaired electron, which renders them highly reactive and capable of 
causing oxidative damage to all the major macro-molecules in cells, including lipids, proteins 
and nucleic acids. A major family of free radicals is the reactive oxygen species, derived 
metabolically from molecular oxygen via super oxide anions. Oxidative attack on proteins results 
in the formation of protein carbonyls often with the loss of functionality of the parent protein 4.  
Polyunsaturated fatty acids, which are major components of cell membranes, can also undergo 
free radical attack, producing lipid peroxidation products like malondialdehyde (MDA) and 4-
hydroxynonenal. Under normal circumstances, the body is protected from such damage by a 
careful balance between pro-oxidants and antioxidants. In extra vascular spaces, the sulphydryls 
group of plasma proteins, including plasma albumin serve as antioxidants with enzymes and  
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Scavenging chemicals such as Vitamin C and vitamin E also having antioxidant activities 5.  
Catalases are enzymes that catalyze the conversion of hydrogen peroxide to water and oxygen, 
using either an iron or manganese cofactor 6. This protein is localized in peroxisomes in most 
eukaryotic cells. Catalase is an unusual enzyme since, although hydrogen peroxide is its only 
substrate, it follows a ping-pong mechanism. Here, its cofactor is oxidized by one molecule of 
hydrogen peroxide and then regenerated by transferring the bound oxygen to a second molecule 
of substrate 7.  
Treatment with antiretroviral drugs (ARD) and Highly Active Retroviral Therapies (HAART) 
may result in biochemical and physiological changes e.g. oxidative damage resulting from the 
presence of free radicals or the absence of antioxidants 8. 
 
Materials and Methods 
Antiretroviral drugs 
Four antiretroviral drugs namely efavirenz, abacavir, lamivudine and SNP 40 (stavudine, 
lamivudine and nevirapine) were used during the course of this study. The drugs were obtained 
from PEPFAR, University Teaching Hospital (UCH), Ibadan, Nigeria. 
 
Animals and Treatment 
Thirty albino rats, purchased from the animal house, Biochemistry and Molecular Biology Unit, 
Department of Biological Sciences, Covenant University, Ota, Ogun State, Nigeria were housed 
and allowed to acclimatized for one week in the animal house of the Biochemistry Unit, 
Department of Chemical Sciences, Bells University of Technology, Ota, Ogun state, Nigeria. 
They were fed with normal rat chow purchased from Agro Vet Ventures, Ota, Ogun State, 
Nigeria and water ad libitum. The rats were randomly divided into five groups and kept in 
wooden cages with wooden shaven beddings in a well ventilated room. All experimental groups 
shared the same environmental conditions. Groups 5 served as the control and were treated with 
physiological saline. Rats in groups 1, 2, 3, and 4 were respectively treated with efavirenz (0.43 
mg /kg), abacavir (0.43 mg/kg), SNP 40 (0.27 mg/kg) and lamivudine (0.21mg/kg). The  
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drugs were administered orally for seven consecutive days. Animals were sacrificed twelve 
 hours after the last treatment. All necessary ethical approval as regards animal use and treatment 
were obtained from the University. 
Lipid peroxidation: Lipid peroxidation in post mitochondrial fraction was estimated 
spectrophotometrically by thiobarbituric acid reactive substances (TBARS) method described by 
Varshney and Kale 9. 
Catalase: Microsomal catalase activity was determined according to the method described by 
Sinha 10. 
Statistical Analysis 
All data are expressed as Mean±SEM (standard error of mean). Significant differences were 
tested using the student t-test. Values of p<0.05 were considered statistically significant 11, 12. 
 
Results and Discussion 
Efavirenz: A significant (p<0.05) decrease in the level of lipid peroxidation in the liver was 
observed but it has no significant (p>0.05) effect on lipid peroxidation level in the kidney. 
Abacavir: It shows a significant (p<0.05) increase in the level of lipid peroxidation in the liver 
whereas a reversal was the case in the kidneys of experimental rats. 
SNP 40: This antiretroviral drugs resulted in a significant (p<0.05) elevation of lipid 
peroxidation level in the liver but shows no significant change (p>0.05) in the level of lipid 
peroxidation in the kidney. 
Lamivudine: The acute administration of lamivudine brought about a significant (p<0.05) 
decrease in lipid peroxidation level in the liver but has no significant (p>0.05) effect on the level 
in the kidney. 
All the antiretroviral drugs administered caused significant increase (P<0.05) in Catalase activity 
in the liver and a significant decrease (P<0.05) in Catalase activity in the kidney. These results 
are illustrated graphically in the figure-1 and figure-2 below. 
The present study was designed to investigate the effect of selected antiretroviral drugs on 
oxidative stress markers when administered in the absence of the Human Immunodeficiency 
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Virus (HIV). Since studies have shown that HIV infection is accompanied with a progression in 
the oxidative stress process 1, 8, 13, 14, 15, any antiretroviral drug whose administration potentially 
result in oxidative stress in non-infected animals would only worsen the oxidative damage in 
HIV- infected animals 16.  
Antiretroviral drugs may induce (i) an increase in oxidant generation, (ii) a decrease in anti-
oxidant protection, or (iii) a failure to repair oxidative damage. Oxidative stress-mediated cell 
damage occurs, in part, via reactive oxygen species (ROS). ROS include molecules like 
hydrogen peroxide; ions like the hypochlorite ion; radicals like the hydroxyl radical; and the 
super oxide anion which is both ion and radical. Radicals (also called "free radicals") are a 
cluster of atoms that contain an unpaired electron in their outermost orbit of electrons. This is an 
extremely unstable configuration, and radicals quickly react with other molecules or radicals to 
achieve the stable configuration. Once formed, ROS participate in a number of reactions, 
yielding additional free radicals such as hydrogen peroxide, peroxynitrite, or hypochlorous acid 
17, 18. The free radicals in HIV infection could result also from non-enzymatic protein oxidation 
and the subsequent oxidative degradation of glycated proteins. 
We noticed that, increase in oxidative stress marker (MDA) in the liver was brought about by 
only the drug abacavir, which has been reported to cause a drug –induced hepatotoxicity  19, 20,21. 
Efavirenz and lamivudine have also been reported to be hepatotoxic 19,20,21 .The fact that they did 
not result in any increase in lipid peroxidation level when compared to the control group does not 
invalidate the above claims but could mean that the drugs probably cause hepatic damage 
through other mechanism(s) other than by oxidative stress. SNP 40 shows a significant elevation 
in the lipid peroxidation level in the liver thereby suggesting an initiation in the oxidative stress 
process. However, our previous findings suggest that SNP 40 may not cause significant hepatic 
damage in short term administration. This then means that either the oxidative stress process 
initiated by the drug was reversible or the time was too short to get an observable hepatic 
damage. We should also bear in mind that SNP 40 being a combined retroviral therapy was 
designed to achieve both increased efficacy and reduced side-effects 22, 23, 24. However, there is 
need for further work to really clarify and substantiate these findings, especially those involving 
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long term administration of the drug. 
The results of the effect of the antiretroviral drugs on the lipid peroxidation level in the kidney 
suggest that in short term oral administration , these drugs may not be involved in the initiation 
or on set of drug –induced nephrotoxicity following oxidative stress. Even in HIV-infected 
individuals, drug- related renal toxicity from the use of antiretroviral drugs are very few and only 
those with the history of kidney failure or kidney diseases have been reported to have problems 
metabolizing antiretroviral drugs. Most antiretroviral agents are relatively free of renal toxicity 
25, 26, 27, 28, 29. Our results further indicate that the antiretroviral drugs increased catalase activities 
in the liver. This could be due to the response of liver to an increased production of reactive 
oxygen species or probably an induction of the enzyme by the drugs and/or their metabolites. 
The observed overall decreased of the catalase activities in the kidney suggest that the organ may 
not be able to protect itself from cellular damage (especially those caused by hydrogen peroxide) 
in the case of hydrogen peroxide and hydroxyl radical – induced oxidative stress. It is generally 
accepted that hydrogen peroxide can be detoxified by catalase, which removes it when present at 
high concentration and glutathione peroxidase, which destroys it when present at a steady state 
30. 
 
Conclusion 
Taken together, the present observation suggests that the effects of antiretroviral drugs on 
oxidative stress markers (such as MDA) and on antioxidant enzymes (such as catalase) in healthy 
as well as in HIV infected humans (by way of extrapolation) may vary from drug to drug and 
from organ to organ. We therefore advocate for extensive clinical research to investigate the 
influence of antiretroviral drugs on antioxidants enzymes in HIV and HIV/AIDS patients. 
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Figure- 1: Effect of Antiretroviral Drugs on Lipid Peroxidation 
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Figure- 2: Effect of Antiretroviral Drugs on Catalase Activity. 
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